Get the Stockscreener App
1.72
2.38%
0.04
After Hours:
1.76
0.04
+2.33%
China Pharma Holdings Inc. stock is traded at $1.72, with a volume of 36,448.
It is up +2.38% in the last 24 hours and down -22.52% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.68
Open:
$1.675
24h Volume:
36,448
Relative Volume:
0.35
Market Cap:
$5.15M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-5.119
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
-6.01%
1M Performance:
-22.52%
6M Performance:
-8.99%
1Y Performance:
-34.97%
1-Day Range:
$1.60
$1.72
1-Week Range:
$1.58
$1.8788
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.72 | 5.15M | 5.54M | -4.74M | -750.60K | -0.336 |
|
RGC
Regencell Bioscience Holdings Ltd
|
22.95 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
157.77 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.49 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.08 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.09 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
China pharma projects disrupted by Sino-US tensions - Reuters
CPHI Price Target: Can CPHI Reach $4? Trading Analysis and Key Levels - Blockchain News
CPHI Stock Squeeze Alert: Potential Short Squeeze Trading Opportunity Analyzed - Blockchain News
CPHI’s Stock Market Adventure: -20.60% YTD Growth Amidst Volatility - investchronicle.com
CPHI Stock Surges with Above-Average Volume: Key Trading Insights and Crypto Market Impact - Blockchain News
CPHI High Conviction Stock Analysis: Potential for Overnight Surge Similar to JZ and SRMTrading Strategies and Crypto Market Impact - Blockchain News
US pharma bets big on China to snap up potential blockbuster drugs - Yahoo Finance
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL - Yahoo Finance
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
Kalkine : China Pharma Shares Moved on NYSE Composite This Week - Kalkine Media
China Pharma (NYSE:CPHI) Shares Down 0.2% – Here’s What Happened - Defense World
CPHI Stock Surge: Key Price Levels and Crypto Market Implications for 2025 - Blockchain News
Trump tariffs live updates: US, China agree on plan to ease trade tensions as US appeals court allows tariffs to remain in effect - Yahoo Finance
Trump tariffs live updates: US-China trade framework set, now awaits Trump and Xi nod - Yahoo Finance
PBM and CPHI Stock Analysis: Trading Signals and Crypto Market Impact for 2024 - Blockchain News
Trump tariffs live updates: Trump hikes steel and aluminum tariffs to 50%, spares UK - Yahoo Finance
Trump’s tariff threat exposes China’s tight grip on the global pharmaceuticals industry - CNN
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report - Yahoo Finance
CPHI Stock Analysis: Current Position and Dry Eye Device Catalyst Update - Blockchain News
Jane Street Group LLC Has $508,000 Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Deutsche Bank AG Increases Stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) - Defense World
$CPHI Stock Surges on Unusual Volume: Real-Time Trading Analysis and Crypto Market Impact - Blockchain News
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
Chinese firm Livzon spends over $219 mln to acquire 64.8% stake in Vietnam's Imexpharm - Theinvestor
Drug Discovery Services Market 2025–2032: Value Chain Analysis and Key Growth Contributors - newstrail.com
$CPHI Stock Surges with Unusual Volume: Crypto Market Implications and Real-Time Analysis - Blockchain News
China Pharma (NYSE:CPHI) Stock Rating Upgraded by StockNews.com - Defense World
HSI Up 348 pts; HSTI Up 60 pts; CSPC PHARMA Up over 6%; BYD COMPANY, CHINA MOBILE, HSBC HOLDINGS, BOC HONG KONG, 3SBIO Hit New Highs; Market Turnover Rises - AASTOCKS.com
Royalty Pharma plc (NASDAQ:RPRX) Holdings Trimmed by Captrust Financial Advisors - Defense World
Tariffs live updates: Bessent says tariffs may return to 'reciprocal' levels if deals aren't made - Yahoo Finance
Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake - Yahoo Finance
Inozyme Pharma, Emerson Electric, Stanley Black & Decker - TradingView
Nuance Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-CHINA Trial for COPD - Yahoo Finance
FTSE 100 LIVE: Stocks rise on US-China hopes, miners rally whilst AstraZeneca tumbles - Proactive Investors
Trump tariffs live updates: Trump hails 'very good progress' as US-China talks continue - Yahoo Finance
Trump tariffs live updates: Trump floats slashing China tariffs to 80% with 'many' deals 'in the hopper' - Yahoo Finance
Trump tariffs live updates: Trump announces UK trade deal with US-China trade talk date set - Yahoo Finance
Trump tariffs live updates: Trump meets with Canada's Carney, hints at coming pharma tariffs - Yahoo Finance
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Trump tariffs live updates: China says 'door is open' to trade talks with the US - Yahoo Finance
US business lobby in China: Some pharma firms reporting tariff exemptions - Yahoo
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines - Yahoo Finance
Is China Pharma Holdings Inc (AMEX: CPHI) A Good Investment For New Investors Now? - Stocksregister
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance
Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews
27.81%! LONGi Refreshes the World Record for the Efficiency of Monocrystalline Silicon Cells Again - digitalmore.co
WuXi group wrestles with uncertainty over pharma tariffs - Bamboo Works
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance
China Pharma Holdings, Inc. Announces Launch of N95 Medical Protective Mask - marketscreener.com
CPHI stock touches 52-week high of $1.4 amid market fluctuations By Investing.com - Investing.com South Africa
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):